Pharma News

AstraZeneca has unveiled late-stage data backing use of its triple combination therapy PT010 in patients with chronic obstructive pulmonary disease (COPD).

US regulators have approved Teva’s Ajovy for the preventative treatment of migraine in adults.

Irish pharma Allergan is buying privately-held, clinical-stage US biotech Bonti for access to its novel, fast-acting neurotoxin programmes for aesthetic and therapeutic applications.

Ironwood Pharmaceuticals has secured fast track designation from the US Food and Drug Administration (FDA) for praliciguat (IW-1973) for the treatment of patients with heart failure wi...

OncoResponse, an immunotherapy company developing a portfolio of novel antibodies for cancer, has announced the completion of a $40m series B equity financing.

Boehringer Ingelheim has purchased all shares of Austrian biopharmaceutical firm, ViraTherapeutics, in a deal valued at around €210m.

The amoeba Naegleria fowleri is commonly found in warm swimming pools, lakes and rivers.

If you're looking into the mouth of a brown bear, one of the world's top predators, your chances of survival probably aren't good.

Scientists have detected traces of 32 pharmaceutical substances in the River Tagus as part of an ongoing investigation, according to a statement released by the University of Lisbon on Wednesday.

Scientists have discovered a new pain center in the brain that they may be able to 'turn off' to relieve agony for chronic nerve sensitivity.

A NEW cancer vaccine has proved to be 100 PERCENT effective when treating aggressive melanomas in mice in a huge breakthrough in a fight against the disease.

(Reuters) - Bristol-Myers Squibb said on Wednesday its experimental drug helped reduce the severity of the most common form of psoriasis in a mid-stage trial.